JPRN-jRCTs032210292招募中1 期
A phase I dose escalation study of carbon-ion radiotherapy for pancreatic cancer
Yamada Shigeru0 个研究点目标入组 24 人开始时间: 2021年9月2日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Histologically or clinically diagnosed primary pancreatic tumor
- •(2) No indication for curative resection or no desire for surgery
- •(3) Has evaluable disease
- •(4) No obvious distant metastasis
- •(5) Age at the time of enrollment is 20 years or older
- •(6) Have a performance status (EGOG) of 0-2
- •(7) No prior surgical resection*1 or radiation therapy for pancreatic cancer
- •*1: Excluding simple laparotomy, gastrojejunostomy, and bile duct jejunal anastomosis
- •(8) Patients who are estimated to have a chance of survival for at least 3 months
- •(9) Patient's written consent for participation in the study has been obtained.
排除标准
- •(1) Tumor involvement in the mucosal surface of the gastrointestinal tract
- •(2) A metal stent has been inserted.
- •(3) Active gastroduodenal ulcer is present
- •(4) Active and refractory infection in the irradiated area
- •(5) Patient has serious complications
- •(6) History of radiation therapy in the area
- •(7) It is judged that it is difficult to carry out this study for medical, psychological, or other reasons. Other reasons that the physician deems inappropriate for enrollment in this study
- •(8) Adult who lacks the capacity to give consent
- •(9) Eligible for the clinical trial of [A clinical trial for efficacy and safety on carbon-ion radiotherapy and concurrent GEM chemotherapy for locally advanced pancreatic cancer] (jRCT1031190131)
研究者
相似试验
已完成
1 期
Phase I radiaition dose escalation study of intensity-modulated radiotherapy with end-exhalation breath-hold technique, combined with full-dose gemcitabine for patients with locally advanced pancreatic cancer.Pancreatic cancerJPRN-UMIN000004589Department of Therapeutic Radiology, Kyoto University Hospital18
暂停
1 期
4fr.CIRT for high risk-prostate cancer + dose measurementD011471Prostate cancerJPRN-jRCTs032190180Tsuji Hiroshi40
已完成
1 期
A Phase I/II trial of radical carbon-ion radiotherapy using 4 fractions for the patients with low- or intermediate-risk prostate cancerProstate cancerJPRN-UMIN000032340Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology60
招募中
1 期
A phase I/II clinical trial of carbon ion radiotherapy with concurrent S-1 for operable pancreatic cancer(HIMAT1325)operable pancreatic cancerJPRN-UMIN000016436Ion Beam Therapy Center20
已完成
不适用
A phase I/II clinical study of Carbon Ion Radiotherapy using 1 fraction for Liver Metastasis from Colorectal CancerColon cancer liver metastasisJPRN-UMIN000032911ational Institutes for Quantum and Radiological Sciences and Technology30